PROQR THERAPEUTICS II B.V

Organization

NL-2333 CR LEIDEN, NL

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Chemically modified single-stranded rna-editing oligonucleotides
- Patent number 12,203,072
- Issue date Jan 21, 2025
- ProQR Therapeutics II B.V.
- Janne Juha Turunen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense oligonucleotides for the treatment of Stargardt disease
- Patent number 12,180,471
- Issue date Dec 31, 2024
- ProQR Therapeutics II B.V.
- Aliye Seda Yilmaz-Elis
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Single-stranded RNA-editing oligonucleotides
- Patent number 12,018,257
- Issue date Jun 25, 2024
- ProQR Therapeutics II B.V.
- Janne Juha Turunen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotide therapy for Leber congenital amaurosis
- Patent number 11,920,132
- Issue date Mar 5, 2024
- ProQR Therapeutics II B.V.
- Patricia Coromoto Biasutto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleic acid molecules for pseudouridylation
- Patent number 11,866,702
- Issue date Jan 9, 2024
- University of Rochester
- Bart Klein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chemically modified single-stranded RNA-editing oligonucleotides
- Patent number 11,851,656
- Issue date Dec 26, 2023
- ProQR Therapeutics II B.V.
- Janne Juha Turunen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Targeted RNA editing
- Patent number 11,781,134
- Issue date Oct 10, 2023
- ProQR Therapeutics II B.V.
- Bart Klein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Single-stranded RNA-editing oligonucleotides
- Patent number 11,649,454
- Issue date May 16, 2023
- ProQR Therapeutics II B.V.
- Janne Juha Turunen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense oligonucleotides for the treatment of eye disease
- Patent number 11,479,771
- Issue date Oct 25, 2022
- ProQR Therapeutics II B.V.
- Hester Catharina Van Diepen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotide complexes for use in RNA editing
- Patent number 11,274,300
- Issue date Mar 15, 2022
- ProQR Therapeutics II B.V.
- Antti Aalto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotides to treat eye disease
- Patent number 11,123,360
- Issue date Sep 21, 2021
- ProQR Therapeutics II B.V.
- Hester Catharina Van Diepen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Single-stranded RNA-editing oligonucleotides
- Patent number 10,988,763
- Issue date Apr 27, 2021
- ProQR Therapeutics II B.V.
- Janne Juha Turunen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chemically modified single-stranded RNA-editing oligonucleotides
- Patent number 10,941,402
- Issue date Mar 9, 2021
- ProQR Therapeutics II B.V.
- Janne Juha Turunen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense oligonucleotides for use in treating Alzheimer's disease
- Patent number 10,900,041
- Issue date Jan 26, 2021
- ProQR Therapeutics II B.V.
- Thomas Petrus Gerardus De Vlaam
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotide therapy for Leber Congenital Amaurosis
- Patent number 10,889,817
- Issue date Jan 12, 2021
- ProQR Therapeutics II B.V.
- Patricia Coromoto Biasutto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of single-stranded antisense oligonucleotide in prevention or t...
- Patent number 10,760,076
- Issue date Sep 1, 2020
- ProQR Therapeutics II B.V.
- Peter Adamson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted RNA editing
- Patent number 10,676,737
- Issue date Jun 9, 2020
- ProQR Therapeutics II B.V.
- Bart Klein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotides to treat eye disease
- Patent number 10,617,707
- Issue date Apr 14, 2020
- ProQR Therapeutics II B.V.
- Hester Catharina Van Diepen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense oligonucleotides for the treatment of eye disease
- Patent number 10,612,025
- Issue date Apr 7, 2020
- ProQR Therapeutics II B.V.
- Hester Catharina Van Diepen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotide therapy for leber congenital amaurosis
- Patent number 10,421,963
- Issue date Sep 24, 2019
- ProQR Therapeutics II B.V.
- Patricia Coromoto Biasutto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for increasing the activity of a cystic fibrosis transmembra...
- Patent number 9,994,856
- Issue date Jun 12, 2018
- ProQR Therapeutics II B.V.
- Daniel Anton De Boer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oligonucleotides for making a change in the sequence of a target RN...
- Patent number 9,605,255
- Issue date Mar 28, 2017
- ProQR Therapeutics II B.V.
- Daniel Anton De Boer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES
- Publication number 20240417721
- Publication date Dec 19, 2024
- ProQR Therapeutics II B.V.
- Janne Juha TURUNEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHEMICALLY MODIFIED SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES
- Publication number 20240271131
- Publication date Aug 15, 2024
- ProQR Therapeutics II B.V.
- Janne Juha Turunen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NUCLEIC ACID MOLECULES FOR PSEUDOURIDYLATION
- Publication number 20240229030
- Publication date Jul 11, 2024
- University of Rochester
- Bart Klein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE OLIGONUCLEOTIDES FOR USE IN THE TREATMENT OF CORNEAL DYST...
- Publication number 20240141340
- Publication date May 2, 2024
- ProQR Therapeutics II B.V.
- Elisabeth Laurentina Wilhelmina Maria VAN MIERLO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TARGETED RNA EDITING
- Publication number 20240141336
- Publication date May 2, 2024
- ProQR Therapeutics II B.V.
- Bart Klein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NUCLEIC ACID MOLECULES FOR PSEUDOURIDYLATION
- Publication number 20240132890
- Publication date Apr 25, 2024
- University of Rochester
- Bart Klein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE OLIGONUCLEOTIDES FOR RNA EDITING
- Publication number 20230323346
- Publication date Oct 12, 2023
- ProQR Therapeutics II B.V.
- Lenka VAN SINT FIET
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES
- Publication number 20230279392
- Publication date Sep 7, 2023
- ProQR Therapeutics II B.V.
- Janne Juha Turunen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNA EDITING INHIBITORS AND METHODS OF USE
- Publication number 20230235322
- Publication date Jul 27, 2023
- ProQR Therapeutics II B.V.
- Janne Juha Turunen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE OLIGONUCLEOTIDES FOR USE IN THE TREATMENT OF USHER SYNDROME
- Publication number 20230134677
- Publication date May 4, 2023
- ProQR Therapeutics II B.V.
- Jim Swildens
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Antisense oligonucleotides for nucleotide deamination in the treatm...
- Publication number 20230039928
- Publication date Feb 9, 2023
- ProQR Therapeutics II B.V.
- Jim Swildens
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE RNA EDITING OLIGONUCLEOTIDES COMPRISING CYTIDINE ANALOGS
- Publication number 20220307023
- Publication date Sep 29, 2022
- ProQR Therapeutics II B.V.
- Janne Juha Turunen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OPTHALMIC COMPOSITIONS COMPRISING VISCOSIFYING POLYMERS AND NUCLEIC...
- Publication number 20220265695
- Publication date Aug 25, 2022
- ProQR Therapeutics II B.V.
- Gerardus Johannes PLATENBURG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF USHER SYNDROME
- Publication number 20220213478
- Publication date Jul 7, 2022
- ProQR Therapeutics II B.V.
- Jim Swildens
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE OLIGONUCLEOTIDES FOR IMMUNOTHERAPY
- Publication number 20220177894
- Publication date Jun 9, 2022
- ProQR Therapeutics II B.V.
- Aliye Seda Yilmaz-Elis
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE OLIGONUCLEOTIDES FOR NUCLEIC ACID EDITING
- Publication number 20220127609
- Publication date Apr 28, 2022
- ProQR Therapeutics II B.V.
- Julien Auguste Germain Boudet
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNA-EDITING OLIGONUCLEOTIDES FOR THE TREATMENT OF USHER SYNDROME
- Publication number 20220112495
- Publication date Apr 14, 2022
- ProQR Therapeutics II B.V.
- Lenka Van Sint Fiet
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF LEBER`S CONGENITAL...
- Publication number 20220098584
- Publication date Mar 31, 2022
- ProQR Therapeutics II B.V.
- Jim Swildens
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OLIGONUCLEOTIDES TO TREAT EYE DISEASE
- Publication number 20210401871
- Publication date Dec 30, 2021
- ProQR Therapeutics II B.V.
- Hester Catharina VAN DIEPEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES
- Publication number 20210340529
- Publication date Nov 4, 2021
- ProQR Therapeutics II B.V.
- Janne Juha Turunen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHEMICALLY MODIFIED SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES
- Publication number 20210238597
- Publication date Aug 5, 2021
- ProQR Therapeutics II B.V.
- Janne Juha Turunen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
STEREOSPECIFIC LINKAGES IN RNA EDITING OLIGONUCLEOTIDES
- Publication number 20210230590
- Publication date Jul 29, 2021
- ProQR Therapeutics II B.V.
- Julien Auguste Germain Boudet
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OLIGONUCLEOTIDE THERAPY FOR LEBER CONGENITAL AMAUROSIS
- Publication number 20210139905
- Publication date May 13, 2021
- ProQR Therapeutics II B.V.
- Patricia Coromoto BIASUTTO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF STARGARDT DISEASE
- Publication number 20210115439
- Publication date Apr 22, 2021
- ProQR Therapeutics II B.V.
- Aliye Seda Yilmaz-Elis
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE OLIGONUCLEOTIDES FOR RNA EDITING
- Publication number 20210079393
- Publication date Mar 18, 2021
- ProQR Therapeutics II B.V.
- Julien Auguste Germain Boudet
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NUCLEIC ACID MOLECULES FOR PSEUDOURIDYLATION
- Publication number 20210010002
- Publication date Jan 14, 2021
- University of Rochester
- Bart Klein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF SINGLE-STRANDED ANTISENSE OLIGONUCLEOTIDE IN PREVENTION OR T...
- Publication number 20200362348
- Publication date Nov 19, 2020
- ProQR Therapeutics II B.V.
- Peter Adamson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OLIGONUCLEOTIDES TO TREAT EYE DISEASE
- Publication number 20200237802
- Publication date Jul 30, 2020
- ProQR Therapeutics II B.V.
- Hester Catharina VAN DIEPEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TARGETED RNA EDITING
- Publication number 20200199586
- Publication date Jun 25, 2020
- ProQR Therapeutics II B.V.
- Bart Klein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF EYE DISEASE
- Publication number 20200181616
- Publication date Jun 11, 2020
- ProQR Therapeutics II B.V.
- Hester Catharina VAN DIEPEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
98718910 - PROQR
- Serial number 98718910
- Filing date Aug 27, 2024
- ProQR Therapeutics II B.V.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
98718988 - PROQR
- Serial number 98718988
- Filing date Aug 27, 2024
- ProQR Therapeutics II B.V.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
79192823 - AXIOMER
- Serial number 79192823
- Registration number 5229979
- Filing date Mar 23, 2016
- ProQR Therapeutics II B.V.
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
Information Trademark
79178642 - PROQR
- Serial number 79178642
- Registration number 5084211
- Filing date Sep 29, 2015
- ProQR Therapeutics II B.V.
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry

PROQR THERAPEUTICS II B.V

Organization

Patents Grantslast 30 patents

Chemically modified single-stranded rna-editing oligonucleotides

Antisense oligonucleotides for the treatment of Stargardt disease

Single-stranded RNA-editing oligonucleotides

Oligonucleotide therapy for Leber congenital amaurosis

Nucleic acid molecules for pseudouridylation

Chemically modified single-stranded RNA-editing oligonucleotides

Targeted RNA editing

Single-stranded RNA-editing oligonucleotides

Antisense oligonucleotides for the treatment of eye disease

Oligonucleotide complexes for use in RNA editing

Oligonucleotides to treat eye disease

Single-stranded RNA-editing oligonucleotides

Chemically modified single-stranded RNA-editing oligonucleotides

Antisense oligonucleotides for use in treating Alzheimer's disease

Oligonucleotide therapy for Leber Congenital Amaurosis

Use of single-stranded antisense oligonucleotide in prevention or t...

Targeted RNA editing

Oligonucleotides to treat eye disease

Antisense oligonucleotides for the treatment of eye disease

Oligonucleotide therapy for leber congenital amaurosis

Method for increasing the activity of a cystic fibrosis transmembra...

Oligonucleotides for making a change in the sequence of a target RN...

Patents Applicationslast 30 patents

SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES

CHEMICALLY MODIFIED SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES

NUCLEIC ACID MOLECULES FOR PSEUDOURIDYLATION

ANTISENSE OLIGONUCLEOTIDES FOR USE IN THE TREATMENT OF CORNEAL DYST...

TARGETED RNA EDITING

NUCLEIC ACID MOLECULES FOR PSEUDOURIDYLATION

ANTISENSE OLIGONUCLEOTIDES FOR RNA EDITING

SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES

RNA EDITING INHIBITORS AND METHODS OF USE

ANTISENSE OLIGONUCLEOTIDES FOR USE IN THE TREATMENT OF USHER SYNDROME

Antisense oligonucleotides for nucleotide deamination in the treatm...

ANTISENSE RNA EDITING OLIGONUCLEOTIDES COMPRISING CYTIDINE ANALOGS

OPTHALMIC COMPOSITIONS COMPRISING VISCOSIFYING POLYMERS AND NUCLEIC...

ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF USHER SYNDROME

ANTISENSE OLIGONUCLEOTIDES FOR IMMUNOTHERAPY

ANTISENSE OLIGONUCLEOTIDES FOR NUCLEIC ACID EDITING

RNA-EDITING OLIGONUCLEOTIDES FOR THE TREATMENT OF USHER SYNDROME

ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF LEBER`S CONGENITAL...

OLIGONUCLEOTIDES TO TREAT EYE DISEASE

SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES

CHEMICALLY MODIFIED SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES

STEREOSPECIFIC LINKAGES IN RNA EDITING OLIGONUCLEOTIDES

OLIGONUCLEOTIDE THERAPY FOR LEBER CONGENITAL AMAUROSIS

ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF STARGARDT DISEASE

ANTISENSE OLIGONUCLEOTIDES FOR RNA EDITING

NUCLEIC ACID MOLECULES FOR PSEUDOURIDYLATION

USE OF SINGLE-STRANDED ANTISENSE OLIGONUCLEOTIDE IN PREVENTION OR T...

OLIGONUCLEOTIDES TO TREAT EYE DISEASE

TARGETED RNA EDITING

ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF EYE DISEASE

Trademarklast 30 trademarks

98718910 - PROQR

98718988 - PROQR

79192823 - AXIOMER

79178642 - PROQR